Events on 27 September 2023
CONGRESS 2023 - Performance of a new molecular Point-of-Care system for respiratory viruses under field conditions
27/09/2023
The presentation provides an overview on the technology and analytical performance of a new true molecular point of care testing system without need for upfront specimen preparation, and the potential benefits resulting from its use at the point of care. The presentation also discusses key aspects to be considered prior to implementation at the point of care
CONGRESS 2023 - Next-generation molecular diagnostics: Leveraging digital technologies to enhance multiplexing in real-time PCR
27/09/2023
Next-generation molecular diagnostics: Leveraging digital technologies to enhance multiplexing in real-time PCR
CONGRESS 2023 - Career and qualification progression in virology
27/09/2023
The dynamic of virological diagnosis has transformed dramatically over the past few years in light of the Covid-19 pandemic, with significant changes to equipment and technology, workforce, workload and expertise. This presentation looks at those changes and focuses on the challenges observed and how these will continue over the coming years for virology departments across the country.
CONGRESS 2023 - My early career Point-of-Care Testing experience
27/09/2023
This presentation will include how her career progressed to a Point of Care Testing (POCT) role in the Wales Specialist Virology Centre. It will also cover what POCT is; the method of testing, who gets tested and why POCT is crucial in the efforts to achieve the WHO initiative to eliminate Hepatitis C in Wales.
Examples of what a day-in-the-life of a "POCT-er" consists of: mass screening projects, case studies, what has been learnt from testing in prison and in the community (homeless shelters and substance misuse services). The future of POCT: what's on the horizon?
Examples of what a day-in-the-life of a "POCT-er" consists of: mass screening projects, case studies, what has been learnt from testing in prison and in the community (homeless shelters and substance misuse services). The future of POCT: what's on the horizon?
CONGRESS 2023 - Evolution of infectious disease Point-of-Care Testing (POCT) across Wales - National POCT Lead perspective
27/09/2023
Learn how infectious disease POCT services have evolved across Wales. Discover how Louise's role as a Biomedical Scientist has evolved to National infectious disease POCT lead. Discover how POCT projects are contributing towards the World Health Organisations Hepatitis C elimination targets and how we foresee future POCT services expanding.
CONGRESS 2023 - Near-patient testing - (self-collected samples; breath test to bloods)
27/09/2023
The presentation provides an overview on potential benefits and risks of near-patient testing conducted by health care professionals, including testing of self-collected specimens.
CONGRESS 2023 - Monkeypox case management/infection control
27/09/2023
Monkeypox case management/infection control
CONGRESS 2023 - What is new in hepatitis?
27/09/2023
Despite effective treatments and vaccines viral hepatitis remains a massive burden on global health affecting the poorest counties disproportionately. Effective treatments and diagnostics for hepatitis remain outside the reach of most people in resource-poor regions.
In contrast, UK strategies against viral hepatitis have been relatively successful, in particular the prospect of HCV elimination, which is already showing improved outcomes in liver health.
Effective strategies depend on high quality epidemiological data which is gleaned from a wide variety of sources including diagnostic laboratory reporting, sentinel surveillance programs and prospective screening of high-risk groups.
The key components preventing transmission of blood-borne viruses such as donor screening, surveillance of susceptible groups and vaccination are now further enhanced by retrospective case finding from historical data, opt-out screening in emergency departments and high intensity test-and-treat events in prisons.
Biomedical Scientists can make a valuable contribution towards viral hepatitis management by sharing local-level data, enabling practical testing solutions for marginalised groups and working closely with clinical teams.
In contrast, UK strategies against viral hepatitis have been relatively successful, in particular the prospect of HCV elimination, which is already showing improved outcomes in liver health.
Effective strategies depend on high quality epidemiological data which is gleaned from a wide variety of sources including diagnostic laboratory reporting, sentinel surveillance programs and prospective screening of high-risk groups.
The key components preventing transmission of blood-borne viruses such as donor screening, surveillance of susceptible groups and vaccination are now further enhanced by retrospective case finding from historical data, opt-out screening in emergency departments and high intensity test-and-treat events in prisons.
Biomedical Scientists can make a valuable contribution towards viral hepatitis management by sharing local-level data, enabling practical testing solutions for marginalised groups and working closely with clinical teams.
Page 10 of 11